申请人:Merck Sharp & Dohme Corp.
公开号:US08263627B2
公开(公告)日:2012-09-11
The present invention is directed to pyridyl amide compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
本发明涉及吡啶酰胺化合物,其是T型钙通道的拮抗剂,并且在涉及T型钙通道的疾病或疾病的治疗或预防中有用。该发明还涉及包含这些化合物的制药组合物以及在涉及T型钙通道的这些疾病的预防或治疗中使用这些化合物和组合物。